CN Stock MarketDetailed Quotes

002393 Tianjin Lisheng Pharmaceutical

Watchlist
  • 17.34
  • +0.06+0.35%
Market Closed Oct 10 15:00 CST
4.47BMarket Cap11.96P/E (TTM)

Tianjin Lisheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
13.25%744.64M
8.71%364.85M
0.56%1.15B
1.06%911.57M
6.95%657.49M
9.51%335.6M
5.00%1.15B
7.94%902.02M
4.67%614.74M
-6.45%306.46M
Operating revenue
13.25%744.64M
8.71%364.85M
0.56%1.15B
1.06%911.57M
6.95%657.49M
9.51%335.6M
5.00%1.15B
7.94%902.02M
4.67%614.74M
-6.45%306.46M
Other operating revenue
76.95%3.55M
----
27.25%7.7M
----
-23.81%2.01M
----
29.70%6.05M
----
-53.14%2.64M
----
Total operating cost
11.77%630.23M
7.78%309.28M
-3.00%969.53M
-1.25%760.76M
5.88%563.85M
10.39%286.96M
3.83%999.48M
5.23%770.42M
1.67%532.52M
-10.97%259.94M
Operating cost
30.83%326.45M
30.87%172.14M
-3.73%468.15M
-3.67%352.76M
2.57%249.52M
6.70%131.53M
7.00%486.28M
4.75%366.19M
-0.74%243.27M
-10.19%123.28M
Operating tax surcharges
6.84%12.82M
11.24%6.06M
-5.13%22.87M
-2.80%17.27M
-2.51%12M
-13.95%5.45M
7.44%24.11M
6.24%17.76M
10.38%12.31M
6.54%6.33M
Operating expense
6.79%212.3M
-4.68%96.43M
-5.08%318.94M
-1.83%273.17M
6.73%198.8M
16.28%101.17M
-7.41%336.02M
5.39%278.27M
1.68%186.26M
-13.94%87M
Administration expense
9.82%61.1M
1.23%27.54M
-0.74%113.61M
-2.87%77.16M
10.36%55.63M
19.27%27.2M
8.17%114.46M
0.57%79.44M
-1.56%50.41M
-7.91%22.81M
Financial expense
-109.13%-37.12M
-653.75%-17.48M
11.43%-59.66M
38.22%-37.2M
26.90%-17.75M
55.40%-2.32M
22.68%-67.36M
-7.14%-60.21M
6.93%-24.28M
-123.03%-5.2M
-Interest expense (Financial expense)
360.09%1.72M
616.85%922.02K
-14.78%745.83K
-16.04%490.57K
-14.68%374.92K
79.63%128.62K
173.07%875.18K
115.77%584.32K
220.04%439.45K
-14.50%71.6K
-Interest Income (Financial expense)
-114.07%-38.99M
-632.56%-18.41M
11.32%-60.53M
37.93%-37.78M
26.57%-18.22M
52.81%-2.51M
22.09%-68.25M
-7.55%-60.86M
5.77%-24.81M
-122.15%-5.33M
Research and development
-16.70%54.69M
2.74%24.58M
-0.33%105.62M
-12.77%77.6M
1.70%65.65M
-6.99%23.93M
1.82%105.98M
12.65%88.97M
9.00%64.55M
1.90%25.73M
Credit Impairment Loss
-121.43%-34.68K
-67.70%25.07K
216.03%2.62M
1,282.87%305.48K
726.66%161.84K
--77.59K
-7,149.54%-2.26M
-183.17%-25.83K
-156.89%-25.83K
----
Asset Impairment Loss
----
----
-48.97%-29.25M
----
----
----
-30.06%-19.63M
---2.31M
----
----
Other net revenue
-43.83%6.35M
40.77%9.1M
913.65%236.31M
3,325.14%252.91M
76.21%11.3M
53.58%6.47M
-483.04%-29.04M
-54.03%7.38M
-44.68%6.41M
-48.86%4.21M
Fair value change income
--1.12M
----
122.02%621.77K
----
----
----
--280.06K
----
----
----
Invest income
-71.43%3.02M
32.69%8.2M
-34.54%15.5M
49.54%12.09M
85.18%10.56M
51.68%6.18M
23.04%23.68M
-29.64%8.08M
-26.77%5.7M
-44.28%4.08M
-Including: Investment income associates
----
81.51%6.48M
6.19%11.02M
23.10%8.66M
49.07%7.34M
-12.39%3.57M
-20.85%10.38M
-9.67%7.03M
-36.78%4.92M
-44.28%4.08M
Asset deal income
----
----
785.53%238.7M
--238.61M
--14.74K
--14.74K
---34.82M
----
----
----
Other revenue
300.07%2.24M
357.53%873.27K
118.82%8.11M
16.61%1.91M
-23.68%560.61K
42.59%190.87K
9.05%3.71M
-57.37%1.64M
-75.98%734.57K
-85.39%133.86K
Operating profit
15.07%120.75M
17.35%64.67M
255.57%419.81M
190.49%403.73M
18.40%104.94M
8.63%55.11M
-13.76%118.06M
16.20%138.98M
17.91%88.63M
15.65%50.73M
Add:Non operating Income
-62.42%449.97K
-88.51%129.91K
59.40%560.9K
192.71%1.35M
163.15%1.2M
1,775.89%1.13M
-43.21%351.88K
42.89%461.94K
106.49%455.04K
7.37%60.29K
Less:Non operating expense
453.51%562.79K
931.90%17.06K
193.06%152.26K
5,082.02%106.94K
4,826.96%101.68K
1,553.63%1.65K
-87.25%51.95K
-99.34%2.06K
-99.04%2.06K
-99.92%100
Total profit
13.78%120.64M
15.20%64.78M
255.02%420.21M
190.43%404.97M
19.03%106.03M
10.73%56.24M
-13.68%118.36M
16.57%139.44M
18.51%89.08M
15.98%50.79M
Less:Income tax cost
22.13%19.36M
-8.51%8.91M
135.83%58.39M
132.33%62.31M
-7.46%15.85M
10.21%9.74M
64.89%24.76M
22.44%26.82M
23.06%17.13M
14.19%8.83M
Net profit
12.31%101.28M
20.16%55.88M
286.54%361.83M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-23.34%93.61M
15.26%112.62M
17.47%71.95M
16.36%41.95M
Net profit from continuing operation
12.31%101.28M
20.16%55.88M
286.54%361.83M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-23.34%93.61M
15.26%112.62M
17.47%71.95M
16.36%41.95M
Less:Minority Profit
---1.07M
---3.28M
----
----
----
----
----
----
----
----
Net profit of parent company owners
13.50%102.35M
27.22%59.16M
286.54%361.83M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-23.34%93.61M
15.26%112.62M
17.47%71.95M
16.36%41.95M
Earning per share
Basic earning per share
14.29%0.4
28.00%0.32
286.27%1.97
200.00%1.86
-10.26%0.35
8.70%0.25
-23.88%0.51
14.81%0.62
14.71%0.39
15.00%0.23
Diluted earning per share
14.29%0.4
28.00%0.32
286.27%1.97
200.00%1.86
-10.26%0.35
8.70%0.25
-23.88%0.51
14.81%0.62
14.71%0.39
15.00%0.23
Other composite income
329.93%238.67M
-1,847.70%-103.8M
Other composite income of parent company owners
----
----
329.93%238.67M
----
----
----
-1,847.70%-103.8M
----
----
----
Total composite income
12.31%101.28M
20.16%55.88M
5,992.10%600.49M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-107.96%-10.19M
15.26%112.62M
17.47%71.95M
16.36%41.95M
Total composite income of parent company owners
13.50%102.35M
27.22%59.16M
5,992.10%600.49M
204.26%342.67M
25.33%90.18M
10.84%46.5M
-107.96%-10.19M
15.26%112.62M
17.47%71.95M
16.36%41.95M
Total composite income of minority owners
---1.07M
---3.28M
----
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 13.25%744.64M8.71%364.85M0.56%1.15B1.06%911.57M6.95%657.49M9.51%335.6M5.00%1.15B7.94%902.02M4.67%614.74M-6.45%306.46M
Operating revenue 13.25%744.64M8.71%364.85M0.56%1.15B1.06%911.57M6.95%657.49M9.51%335.6M5.00%1.15B7.94%902.02M4.67%614.74M-6.45%306.46M
Other operating revenue 76.95%3.55M----27.25%7.7M-----23.81%2.01M----29.70%6.05M-----53.14%2.64M----
Total operating cost 11.77%630.23M7.78%309.28M-3.00%969.53M-1.25%760.76M5.88%563.85M10.39%286.96M3.83%999.48M5.23%770.42M1.67%532.52M-10.97%259.94M
Operating cost 30.83%326.45M30.87%172.14M-3.73%468.15M-3.67%352.76M2.57%249.52M6.70%131.53M7.00%486.28M4.75%366.19M-0.74%243.27M-10.19%123.28M
Operating tax surcharges 6.84%12.82M11.24%6.06M-5.13%22.87M-2.80%17.27M-2.51%12M-13.95%5.45M7.44%24.11M6.24%17.76M10.38%12.31M6.54%6.33M
Operating expense 6.79%212.3M-4.68%96.43M-5.08%318.94M-1.83%273.17M6.73%198.8M16.28%101.17M-7.41%336.02M5.39%278.27M1.68%186.26M-13.94%87M
Administration expense 9.82%61.1M1.23%27.54M-0.74%113.61M-2.87%77.16M10.36%55.63M19.27%27.2M8.17%114.46M0.57%79.44M-1.56%50.41M-7.91%22.81M
Financial expense -109.13%-37.12M-653.75%-17.48M11.43%-59.66M38.22%-37.2M26.90%-17.75M55.40%-2.32M22.68%-67.36M-7.14%-60.21M6.93%-24.28M-123.03%-5.2M
-Interest expense (Financial expense) 360.09%1.72M616.85%922.02K-14.78%745.83K-16.04%490.57K-14.68%374.92K79.63%128.62K173.07%875.18K115.77%584.32K220.04%439.45K-14.50%71.6K
-Interest Income (Financial expense) -114.07%-38.99M-632.56%-18.41M11.32%-60.53M37.93%-37.78M26.57%-18.22M52.81%-2.51M22.09%-68.25M-7.55%-60.86M5.77%-24.81M-122.15%-5.33M
Research and development -16.70%54.69M2.74%24.58M-0.33%105.62M-12.77%77.6M1.70%65.65M-6.99%23.93M1.82%105.98M12.65%88.97M9.00%64.55M1.90%25.73M
Credit Impairment Loss -121.43%-34.68K-67.70%25.07K216.03%2.62M1,282.87%305.48K726.66%161.84K--77.59K-7,149.54%-2.26M-183.17%-25.83K-156.89%-25.83K----
Asset Impairment Loss ---------48.97%-29.25M-------------30.06%-19.63M---2.31M--------
Other net revenue -43.83%6.35M40.77%9.1M913.65%236.31M3,325.14%252.91M76.21%11.3M53.58%6.47M-483.04%-29.04M-54.03%7.38M-44.68%6.41M-48.86%4.21M
Fair value change income --1.12M----122.02%621.77K--------------280.06K------------
Invest income -71.43%3.02M32.69%8.2M-34.54%15.5M49.54%12.09M85.18%10.56M51.68%6.18M23.04%23.68M-29.64%8.08M-26.77%5.7M-44.28%4.08M
-Including: Investment income associates ----81.51%6.48M6.19%11.02M23.10%8.66M49.07%7.34M-12.39%3.57M-20.85%10.38M-9.67%7.03M-36.78%4.92M-44.28%4.08M
Asset deal income --------785.53%238.7M--238.61M--14.74K--14.74K---34.82M------------
Other revenue 300.07%2.24M357.53%873.27K118.82%8.11M16.61%1.91M-23.68%560.61K42.59%190.87K9.05%3.71M-57.37%1.64M-75.98%734.57K-85.39%133.86K
Operating profit 15.07%120.75M17.35%64.67M255.57%419.81M190.49%403.73M18.40%104.94M8.63%55.11M-13.76%118.06M16.20%138.98M17.91%88.63M15.65%50.73M
Add:Non operating Income -62.42%449.97K-88.51%129.91K59.40%560.9K192.71%1.35M163.15%1.2M1,775.89%1.13M-43.21%351.88K42.89%461.94K106.49%455.04K7.37%60.29K
Less:Non operating expense 453.51%562.79K931.90%17.06K193.06%152.26K5,082.02%106.94K4,826.96%101.68K1,553.63%1.65K-87.25%51.95K-99.34%2.06K-99.04%2.06K-99.92%100
Total profit 13.78%120.64M15.20%64.78M255.02%420.21M190.43%404.97M19.03%106.03M10.73%56.24M-13.68%118.36M16.57%139.44M18.51%89.08M15.98%50.79M
Less:Income tax cost 22.13%19.36M-8.51%8.91M135.83%58.39M132.33%62.31M-7.46%15.85M10.21%9.74M64.89%24.76M22.44%26.82M23.06%17.13M14.19%8.83M
Net profit 12.31%101.28M20.16%55.88M286.54%361.83M204.26%342.67M25.33%90.18M10.84%46.5M-23.34%93.61M15.26%112.62M17.47%71.95M16.36%41.95M
Net profit from continuing operation 12.31%101.28M20.16%55.88M286.54%361.83M204.26%342.67M25.33%90.18M10.84%46.5M-23.34%93.61M15.26%112.62M17.47%71.95M16.36%41.95M
Less:Minority Profit ---1.07M---3.28M--------------------------------
Net profit of parent company owners 13.50%102.35M27.22%59.16M286.54%361.83M204.26%342.67M25.33%90.18M10.84%46.5M-23.34%93.61M15.26%112.62M17.47%71.95M16.36%41.95M
Earning per share
Basic earning per share 14.29%0.428.00%0.32286.27%1.97200.00%1.86-10.26%0.358.70%0.25-23.88%0.5114.81%0.6214.71%0.3915.00%0.23
Diluted earning per share 14.29%0.428.00%0.32286.27%1.97200.00%1.86-10.26%0.358.70%0.25-23.88%0.5114.81%0.6214.71%0.3915.00%0.23
Other composite income 329.93%238.67M-1,847.70%-103.8M
Other composite income of parent company owners --------329.93%238.67M-------------1,847.70%-103.8M------------
Total composite income 12.31%101.28M20.16%55.88M5,992.10%600.49M204.26%342.67M25.33%90.18M10.84%46.5M-107.96%-10.19M15.26%112.62M17.47%71.95M16.36%41.95M
Total composite income of parent company owners 13.50%102.35M27.22%59.16M5,992.10%600.49M204.26%342.67M25.33%90.18M10.84%46.5M-107.96%-10.19M15.26%112.62M17.47%71.95M16.36%41.95M
Total composite income of minority owners ---1.07M---3.28M--------------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data